Background
==========

Sesquiterpene lactones (SQLs) are a diverse and large group of natural metabolites found across the plant kingdom, and approximately 5000 SQLs have been reported so far from plants \[[@b1-medscimonit-25-2852]\]. Over the years, SQLs have received considerable attention owing to their potent bioactivities, such as anticancer and anti-microbial action \[[@b2-medscimonit-25-2852],[@b3-medscimonit-25-2852]\]. A number of SLs have been reported to exhibit significant anticancer activity and many SQLs are currently undergoing clinical trials \[[@b4-medscimonit-25-2852]\]. Anthecotulide is an important SQL, but there have been few studies of the anticancer activity of anthecotulide \[[@b5-medscimonit-25-2852]\]. The present study was designed to examine the anticancer effects of anthecotulide on human malignant melanoma cells. Melanoma is a serious cancer and accounts for about 4% of all cancer-related deaths. It is the sixth most common type of cancer in the United States, where it has been reported that 1 in every 5 individuals develop skin cancer during their lifetime \[[@b6-medscimonit-25-2852]\]. There is strong evidence that exposure to ultraviolet radiation initiates the development of melanoma and much attention has recently been focused on exploring the potential of natural products to protect against UVR-induced skin cancer \[[@b7-medscimonit-25-2852]\]. The treatment of melanoma is generally difficult due its late diagnosis, as well as metastasis to distant organs. Moreover, the insufficient effectiveness of chemotherapeutic drugs, associated adverse effects, and the emergence of drug resistance further make it difficult to treat diseases such as cancer \[[@b8-medscimonit-25-2852]\]. Therefore, the development of more effective and safer chemotherapy from natural sources holds great promise. Herein, for the first time, we report that anthecotulide inhibits the growth of human SK-MEL-24 malignant melanoma cells. The anticancer effects of anthecotulide are mainly due to the induction of apoptosis, accompanied with alteration of the Bax/Bcl-2 ratio and caspase activation. Further, anthecotulide induced autophagy in the SK-MEL-24 cells along with upregulation of LC3 II protein levels. Anthecotulide also concentration-dependently induced the S phase arrest of SK-MEL-24 cells. Several signal transduction pathways are activated in cancer cells, such as NF-κB signalling cascade \[[@b9-medscimonit-25-2852]\]. Herein, we found that anthecotulide inhibits this pathway, indicative of the potent anticancer activity of anthecotulide. To conclude, anthecotulide has potent anticancer activity and may prove useful for the development of chemotherapy for melanoma.

Material and Methods
====================

Cell lines and culture conditions
---------------------------------

The human melanoma cell line SK-MEL-24 cells and the normal HaCat cells were obtained from the Cancer Research Institute of Beijing (Beijing, China) and maintained in Dulbecco's modified Eagle's medium (Invitrogen Life Technologies, MA) supplemented with 10% fetal bovine serum (Invitrogen Life Technologies, MA), 100 μg/ml streptomycin, and 100 U/ml penicillin G (Himedia, PA) in an incubator at 37°C with 5% CO~2~.

Cell viability assay
--------------------

The effect of anthecotulide on the viability of the SK-MEL-24 and HaCat cells was assessed by WST-1 assay. In brief, the melanoma cells were cultured at a density of 2.5×10^5^ cells/well in 96-well plates and subjected to treatment with varied concentrations (0 to 200 μM dissolved in dimethyl sulfoxide) of anthecotulide. The control cells were treated with only 2% DMSO. This followed by the incubatation of the SK-MEL-24 cells with WST-1 for 3 h at 37°C, and the proliferation rate was determined by assessing absorbance at 450 nm using a UV spectrophotometer (Thermo Fisher, Waltham, MA).

Acridine orange and ethidium bromide double staining for the detection of apoptosis
-----------------------------------------------------------------------------------

For AO/EB staining, the SK-MEL-24 cells were grown in 6-well plates (0.6×10^6^ cells/well). Following incubation for 12 h, the SK-MEL-24 cells were subjected to anthecotulide treatment (0, 5, 10, and 20 μM) for 24 h at 37°C. As the cells sloughed off, 25-μl cell cultures were put onto glass slides and subjected to staining with a solution of AO (acridine orange) and EB (ethidium bromide). The slides were then covered with a covers lip and examined with a fluorescence microscope (Thermo Fisher, Waltham, MA).

GFP-LC3 transfection for the detection of autophagy
---------------------------------------------------

For detection of autophagy, the SK-MEL-24 cells were grown to 70% confluence and transfected with GFP-LC3 plasmids using Lipofectamine 2000 (Invitrogen) according to the manufacturer's guidelines. The transfected cells were then treated with various concentrations of anthecotulide (0, 5, 10, and 20 μM) for 24 h and subsequently monitored by fluorescence microscopy (Thermo Fisher, Waltham, MA).

Cell cycle analysis
-------------------

SK-MEL-24 melanoma cells were incubated with various concentrations of anthecotulide (0, 5, 10, and 20 μM) for 24 h. The cells were then subjected to washing with phosphate-buffered saline (PBS). Then, the SK-MEL-24 cells were stained with propidium iodide (PI) and the distribution of the cells in cell cycle phases was assessed by use of a FACS flow cytometer (BD Biosciences, San Jose, CA).

Western blot analysis
---------------------

To determine the expression of the selected proteins in the anthecotulide-treated (0, 5, 10, and 20 μM) malignant melanoma cells, the cells were lysed with RIPA buffer and the protein contents of lysates were estimated by BCA assay. The samples were then loaded on the SDS-PAGE. The gels were then transferred to nitrocellulose membranes and subjected to treatment with primary antibody at 4°C for 24 h. After this, the membranes were incubated with HRP-conjugated secondary antibody for 50 min at 25°C. Enhanced chemiluminescence reagent was used to visualise the protein bands.

Statistical analysis
--------------------

The experiments were performed in triplicate. The values represent mean ±SD. P\<0.05 was regarded as statistically significant. We used the *t* test and GraphPad Prism 7 for statistical analysis.

Results
=======

Anthecotulide inhibits exerts antiproliferative effects on SK-MEL-24 melanoma cells
-----------------------------------------------------------------------------------

The anti-proliferative effects of anthecotulide ([Figure 1A](#f1-medscimonit-25-2852){ref-type="fig"}) on the malignant SK-MEL-24 melanoma cells were examined by WST-1 assay. It was found that that anthecotulide exerts antiproliferative effects on the SK-MEL-24 melanoma cell line and exhibited an IC~50~ of 10 μM ([Figure 1B](#f1-medscimonit-25-2852){ref-type="fig"}), but the anticancer effects of anthecotulide against the normal HaCat cells were minimal (IC~50~; 100 μM). In addition, we found that the anticancer effects of anthecotulide on the melanoma cells occurred in a dose-dependent manner.

Anthecotulide triggers apoptosis in SK-MEL-24 melanoma cells
------------------------------------------------------------

The apoptosis-inducing effects of anthecotulide on the malignant melanoma SK-MEL-24 cells were investigated by AO/EB staining. The results of AO/EB assay showed that anthecotulide induced apoptotic cell death in the SK-MEL-24 melanoma cells ([Figure 2](#f2-medscimonit-25-2852){ref-type="fig"}). Analysis of the protein expression of the apoptosis biomarker proteins revealed that anthecotulide increased the expression of Bax and decreased the expression of Bcl-2. Furthermore, anthecotulide also concentration-dependently triggered activation of caspase 3 and 9 in the SK-MEL-24 cells ([Figure 3](#f3-medscimonit-25-2852){ref-type="fig"}).

Anthecotulide triggers autophagy in SK-MEL-24 melanoma cells
------------------------------------------------------------

We also investigated whether anthecotulide induces autophagy in SK-MEL-24 cells. LC3 II was transiently overexpressed in the SK-MES-4 cells by transfecting the cells with transient pEGFP-LC3 plasmid and then cells were treated with various concentrations of anthecotulide. We found that anthecotulide caused a concentration-dependent increase in the GFP-LC3 punctate dots in the SK-MEL-24 cells, as indicated by fluorescence microscopy ([Figure 4](#f4-medscimonit-25-2852){ref-type="fig"}). This indicates that anthecotulide induced autophagy in SK-MEL-24 cells. For the confirmation of autophagy, the expression of autophagy-associated proteins was examined, showing that asiaticoside caused an increase in levels of Beclin-1 and LC3-II, but no effects were observed on the expression of LC3-I ([Figure 5](#f5-medscimonit-25-2852){ref-type="fig"}).

Anthecotulide causes the S phase cell cycle arrest of SK-MEL-24 melanoma cells
------------------------------------------------------------------------------

The effects of anthecotulide on the distribution of SK-MEL-24 melanoma cells (SK-MEL-24) in various cell cycle phases were assessed by flow cytometry, showing that Anthecotulide caused a remarkable increase in the percentage of SK-MEL-24 melanoma cells in the S phase of the cell cycle. The percentage of SK-MEL-24 esophageal cancer cells in the S phase increased from 15.6% to 32.3% upon treatment with anthecotulide ([Figure 6](#f6-medscimonit-25-2852){ref-type="fig"}). These results clearly indicate that anthecotulide induces S phase cell cycle arrest of SK-MEL-24 melanoma cells. Moreover, S phase cell cycle arrest of SK-MEL-24 cells by anthecotulide was also associated with concentration-dependent suppression of Cyclin B1 and upregulation of p27 expression ([Figure 7](#f7-medscimonit-25-2852){ref-type="fig"}).

Anthecotulide inhibits the NF-κB signalling pathway
---------------------------------------------------

It has been reported that many signalling pathways are activated in cancer cells and these pathways are considered important targets for anticancer drugs. The effect of anthecotulide was also investigated on the NF-κB signalling pathway in SK-MEL-24 cells. We found that anthecotulide causes a large decrease in the expression of the NF-κB proteins and this effect was concentration-dependent ([Figure 8](#f8-medscimonit-25-2852){ref-type="fig"}).

Discussion
==========

Melanoma is a deadly cancer accounting for approximately 4% of all cancer-related deaths \[[@b7-medscimonit-25-2852]\]. The lack of effective drugs, late diagnosis, and emergence of multi-drug resistance makes management of melanoma complicated \[[@b10-medscimonit-25-2852]\]. In the present study we investigated the anticancer effects of a natural SQL, anthecotulide, on SK-MEL-24 melanoma cells. We found that anthecotulide concentration-dependently suppressed the proliferation of SK-MEL-24 melanoma cells and showed an IC~50~ of 10 μM. Although anticancer activities have not been reported previously for anthecotulide, numerous studies have reported the anticancer effects of natural SQLs; for example, parthenolide has been reported to inhibit the growth of cancer cells \[[@b11-medscimonit-25-2852]\]. Similarly, a sesquiterpene lactone, costunolide, has been reported to halt the growth of MCF-7 cells \[[@b12-medscimonit-25-2852]\]. Several of the SQLs have been reported to induce autophagy in cancer cells; for example, helenalin has been reported to induce autophagy in cancer cells \[[@b13-medscimonit-25-2852]\]. Here, we found that anthecotulide induced autophagy in SK-MEL-4 cells, along with upregulation of the LC3 II and Beclin 1 expression. SQLs have also been shown to induce apoptosis in cancer cells, which one of the important mechanisms maintaining homeostasis in human tissues \[[@b14-medscimonit-25-2852]\]. For example, parthenolide has been shown to trigger apoptotic cell death of human acute myelogenous leukemia cells \[[@b15-medscimonit-25-2852]\]. We found that anthecotulide also triggered apoptosis in the SK-MEL-24 cells and was linked with upregulation of Bax and downregulation of Bcl-2 as well as the activation of caspase 3 and 9. Cell cycle arrest is another important mechanism by which anticancer molecules exert their effects \[[@b16-medscimonit-25-2852]\] and here we found that anthecotulide triggered the S phase arrest of SK-MEL-24 melanoma cells, which was associated with suppression of cyclin B1 and upregulation of p27 expressions. A previous study showed that a SQL, a parthenolide, exerts anticancer effects by inhibiting NF-κB \[[@b17-medscimonit-25-2852]\]. Therefore, we also examined the effects of anthecotulide on NF-κB protein expression and found that anthecotulide concentration-dependently inhibited the expression of NF-κB, indicative of its anticancer potential.

Conclusions
===========

Anthecotulide inhibits the growth of malignant melanoma cells by induction of autophagy and apoptosis. It also induces S phase cell cycle arrest and inhibited the NF-κB signalling pathway, suggesting its potential in the management of melanoma. Further investigations are warranted.
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![(**A**) Structure of anthecotulide. (**B**) WST-1 assay showing the effects of anthecotulide on the viability of the SK-MEL-24 melanoma and HaCat normal cells. The experiments were performed in triplicate and results are shown as mean ±SD (p\<0.05).](medscimonit-25-2852-g001){#f1-medscimonit-25-2852}

![AO/EB staining showing the induction of apoptosis in SK-MEL-24 melanoma cells at indicated concentrations. The experiments were performed in triplicate. Green arrows depict normal cells, yellow arrows depict early apoptosis, and the red arrows depict late apoptosis.](medscimonit-25-2852-g002){#f2-medscimonit-25-2852}

![Bax, Bcl-2, and Caspase 3 and 9 expressions after treatment with anthecotulide at indicated concentrations, as depicted by Western blot analysis. The experiments were performed in triplicate.](medscimonit-25-2852-g003){#f3-medscimonit-25-2852}

![Effect of anthecotulide on the expression of LC3 II in PGL-FL3 transfected cells, as indicated by fluorescence microscopy. The experiments were performed in triplicate.](medscimonit-25-2852-g004){#f4-medscimonit-25-2852}

![LC3 I and II and Beclin-1 expression after treatment with anthecotulide at indicated concentrations, as depicted by Western blot analysis. The experiments were performed in triplicate.](medscimonit-25-2852-g005){#f5-medscimonit-25-2852}

![S phase cell cycle arrest as depicted by flow cytometery at indicated concentrations of anthecotulide. The experiments were performed in triplicate.](medscimonit-25-2852-g006){#f6-medscimonit-25-2852}

![Cyclin B and p27 expression after treatment with anthecotulide at indicated concentrations as depicted by Western blot analysis. The experiments were performed in triplicate.](medscimonit-25-2852-g007){#f7-medscimonit-25-2852}

![Effect of anthecotulide on NF-κB expression at indicated concentrations as depicted by Western blot analysis. The experiments were performed in triplicate.](medscimonit-25-2852-g008){#f8-medscimonit-25-2852}
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